Impact and use of reviews and 'overviews of reviews' to inform clinical practice guideline recommendations: protocol for a methods study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
20 Jan 2020
Historique:
entrez: 23 1 2020
pubmed: 23 1 2020
medline: 11 2 2021
Statut: epublish

Résumé

Guidelines are systematically developed recommendations to assist practitioner and patient decisions about treatments for clinical conditions. High quality and comprehensive systematic reviews and 'overviews of systematic reviews' (overviews) represent the best available evidence. Many guideline developers, such as the WHO and the Australian National Health and Medical Research Council, recommend the use of these research syntheses to underpin guideline recommendations. We aim to evaluate the impact and use of systematic reviews with and without pairwise meta-analysis or network meta-analyses (NMAs) and overviews in clinical practice guideline (CPG) recommendations. CPGs will be retrieved from Turning Research Into Practice and Epistemonikos (2017-2018). The retrieved citations will be sorted randomly and then screened sequentially by two independent reviewers until 50 CPGs have been identified. We will include CPGs that provide at least two explicit recommendations for the management of any clinical condition. We will assess whether reviews or overviews were cited in a recommendation as part of the development process for guidelines. Data extraction will be done independently by two authors and compared. We will assess the risk of bias by examining how each guideline developed clinical recommendations. We will calculate the number and frequency of citations of reviews with or without pairwise meta-analysis, reviews with NMAs and overviews, and whether they were systematically or non-systematically developed. Results will be described, tabulated and categorised based on review type (reviews or overviews). CPGs reporting the use of the Grading of Recommendations, Assessment, Development and Evaluation approach will be compared with those using a different system, and pharmacological versus non-pharmacological CPGs will be compared. No ethics approval is required. We will present at the Cochrane Colloquium and the Guidelines International Network conference.

Identifiants

pubmed: 31964662
pii: bmjopen-2019-031442
doi: 10.1136/bmjopen-2019-031442
pmc: PMC7044835
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e031442

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Syst Rev. 2017 Nov 21;6(1):231
pubmed: 29162130
J Clin Epidemiol. 2017 Jan;81:101-110
pubmed: 27713072
J Clin Oncol. 2004 May 15;22(10):2000-7
pubmed: 15143093
Lancet. 2014 Jan 11;383(9912):156-65
pubmed: 24411644
Chest. 1998 Mar;113(3 Suppl):172S-178S
pubmed: 9515888
BMJ. 2001 Aug 11;323(7308):334-6
pubmed: 11498496
JAMA Intern Med. 2019 Apr 1;179(4):584-586
pubmed: 30776054
J Clin Epidemiol. 2016 Jan;69:225-34
pubmed: 26092286
Health Technol Assess. 2015 Apr;19(28):1-99, v-vi
pubmed: 25875129
BMC Med. 2011 Jun 27;9:79
pubmed: 21707969
Ann Intern Med. 1997 Aug 1;127(3):210-6
pubmed: 9245227
Mayo Clin Proc. 2014 Jan;89(1):16-24
pubmed: 24388018
Syst Rev. 2018 Mar 1;7(1):39
pubmed: 29490699
Syst Rev. 2013 Sep 20;2:76
pubmed: 24050381
JAMA. 2019 Mar 19;321(11):1069-1080
pubmed: 30874755
BMJ. 2001 Oct 13;323(7317):833-6
pubmed: 11597966
BMJ. 2002 Mar 2;324(7336):545
pubmed: 11872564
Syst Rev. 2018 Oct 12;7(1):159
pubmed: 30314530
Syst Rev. 2016 Jan 06;5:4
pubmed: 26739283
PLoS Med. 2009 Sep;6(9):e1000151
pubmed: 19753108
Cochrane Database Syst Rev. 2013 May 31;(5):ED000059
pubmed: 23875191
Lancet. 2014 Jan 11;383(9912):101-4
pubmed: 24411643
Syst Rev. 2018 Oct 20;7(1):168
pubmed: 30342549
BMJ. 2003 Nov 29;327(7426):1283-5
pubmed: 14644976
Eval Health Prof. 2002 Mar;25(1):116-29
pubmed: 11868441
PLoS One. 2007 Dec 26;2(12):e1350
pubmed: 18159233

Auteurs

Carole Lunny (C)

Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada carole.lunny@ti.ubc.ca.

Cynthia Ramasubbu (C)

Faculty of Pharmacy, University of British Columbia, Vancouver, British Columbia, Canada.

Savannah Gerrish (S)

Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Tracy Liu (T)

Faculty of Pharmacy, University of British Columbia, Vancouver, British Columbia, Canada.

Douglas M Salzwedel (DM)

Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Lorri Puil (L)

Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Barbara Mintzes (B)

Faculty of Pharmacy and Charles Perkins Centre, University of Sydney Faculty of Health Sciences, The University of Sydney, New South Wales, Australia.

James Jim Wright (JJ)

Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH